ScienceDex / Researcher record
Judy Lynn Aschner
- Hackensack University Medical Center (no department on record)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
- Top 10% Funded
- Multi-Institutional
- Early Career
- Diverse Portfolio
NIH Funding · FY2026
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $4,807,263 | 2 | #1,182 |
| 2025 | $5,857,394 | 2 | #1,099 |
| 2026 | $8,435,003 | 4 | #1,154 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20242 records
- FY20252 records
- FY2026 · selected4 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1916235Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award records by amount
NIH award records listing Judy Lynn Aschner as a PI. Multi-PI records show the full award amount for context.
- 5UH3OD035546-04UH3Contact PIEnriching ECHO Cohorts with High-risk Pregnancies and Children with Health Challenges (Enriching ECHO)$5.2Maward amount
- 1R44HL186892-01R44Co-investigatorA Randomized,Phase 2b/3 Study to Evaluate the Efficacy and Safety of Zelpultide Alfa in Preventing BPD in High-Risk Preterm Neonates Compared to Standard of Care.$1.9Maward amount
- 5UH3OD035513-04UH3Co-investigatorDevelopmental Impact of NICU Exposures (DINE) phase II$890Kaward amount
- 1R61HL185680-01R61Contact PISafety and Pharmacodynamics of L-Citrulline for the Treatment of Pulmonary Hypertension (PH) in Preterm Neonates with Severe Bronchopulmonary Dysplasia (BPD-PH) [CToP BPD-PH]$470.7Kaward amount
Award organizations
Organizations that administered FY2026 awards listing Judy Lynn Aschner as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardHackensack University Medical Center
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #1182
- 2024Entered Top 25% NationallyRanked #1182
- 2024Entered Top 10% NationallyRanked #1182
- 2025$5M Cumulative Funding
- 2025$10M Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 3 institutions
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Judy Lynn Aschner.